数据中心
龙虎榜
大单追踪
资金流向
业绩预告
新股申购
行情中心
沪深市场
香港市场
美国市场
全球市场
行业风云
全球市场
向上 向下

   CVM
-- -- --

今开：-- 昨收：-- 最高：-- 最低：--
成交量：--万手 市盈率：-- 总市值($)：-- 换手率：--
加入自选股

首页概览 公司概况 财务分析 高管介绍 股本结构 公司新闻

股本结构

单位：万股
公告日期 2024-02-09 2024-02-14 2024-02-14 2023-11-16 2023-11-16 2023-12-21
证券总股本 5397.92 5010.42 5001.86 4998.08 4749.08 4742.23
普通股本 5397.92 5010.42 5001.86 4998.08 4749.08 4742.23
优先股 未披露 未披露 未披露 未披露 未披露 未披露
其他 未披露 未披露 未披露 未披露 未披露 未披露
变动日期 2024-02-13 2024-02-07 2023-12-31 2023-11-20 2023-11-15 2023-09-30
注释：中概股证券总股本=普通股股本/ 存托凭证比例

历史变动

公告日期 变动后普通股本（万股） 变动后优先股（万股） 变动原因 变动日期
2024-02-09 5397.92 未披露
更多>>
Common stock offered 3,875,000 shares by the company
2024-02-13
2024-02-14 5010.42 未披露 定期报告 2024-02-07
2024-02-14 5001.86 未披露
更多>>
From September 30, 2023 to December 31, 2023 401(k) contributions paid in common stock Stock issued to nonemployees for service Proceeds from the sale of common stock
2023-12-31
2023-11-16 4998.08 未披露
更多>>
Common stock offered 2,490,000 shares by the company
2023-11-20
2023-11-16 4749.08 未披露 定期报告 2023-11-15
2023-12-21 4742.23 未披露
更多>>
From September 30, 2022 to September 30, 2023 401(k) contributions paid in common stock Stock issued to nonemployees for service Proceeds from the sale of common stock 2014 Incentive Stock Forfeited
2023-09-30
2023-08-10 4726.01 未披露 定期报告 2023-08-08
2023-07-18 4725.01 未披露
更多>>
Common stock offered 2,500,000 shares by the company
2023-07-20
2023-07-17 4475.01 未披露 定期报告 2023-07-14
2023-08-10 4474.84 未披露
更多>>
From March 31, 2023 to June 30, 2023 2014 Incentive Stock Forfeited 401(k) contributions paid in common stock Proceeds from the sale of common stock Stock and options issued to nonemployees for service
2023-06-30
2023-05-12 4471.47 未披露 定期报告 2023-05-08
2023-05-01 4458.37 未披露
更多>>
Common stock offered 794,117 shares by the company
2023-05-02
2023-05-01 4378.95 未披露 定期报告 2023-04-26
2023-05-12 4378.78 未披露
更多>>
From December 31, 2022 to March 31, 2023 401(k) contributions paid in common stock Stock and options issued to nonemployees for service
2023-03-31
2023-04-10 4376.42 未披露 定期报告 2023-03-29
2023-02-14 4373.89 未披露 定期报告 2023-02-10
2023-02-14 4372.56 未披露
更多>>
From SEPTEMBER 30, 2022 to DECEMBER 31, 2022 Warrant exercises 401(k) contributions paid in common stock Stock and options issued to nonemployees for service 2014 Incentive Stock Forfeited
2022-12-31
2022-12-27 4367.99 未披露 定期报告 2022-12-14
2022-12-27 4344.83 未披露
更多>>
From September 30, 2021 to September 30, 2022 Warrant exercises 401(k) contributions paid in common stock Stock issued to nonemployees for service Option exercises
2022-09-30
2022-08-12 4336.75 未披露 定期报告 2022-08-03
2022-08-12 4335.55 未披露
更多>>
From MARCH 31, 2022 to JUNE 30, 2022 401(k) contributions paid in common stock Stock and options issued to nonemployees for service
2022-06-30
2022-07-01 4332.81 未披露 定期报告 2022-06-14
2022-05-13 4332.70 未披露 定期报告 2022-05-09
2022-04-29 4331.56 未披露 定期报告 2022-04-19
2022-05-13 4330.46 未披露
更多>>
From DECEMBER 31, 2021 to MARCH 31, 2022 Warrant exercises 401(k)contributions paid in common stock Stock and options issued to nonemployees for service
2022-03-31
2022-02-11 4327.57 未披露 定期报告 2022-02-02
2022-02-11 4325.90 未披露
更多>>
From OCTOBER 1, 2021 to DECEMBER 31, 2021 Warrant exercises 401(k) contributions paid in common stock Stock and options issued to nonemployees for service Option exercises
2021-12-31
2021-12-21 4324.45 未披露 定期报告 2021-12-10
2021-12-21 4320.72 未披露
更多>>
From September 30, 2020 to September 30, 2021 Proceeds from the sale of common stock Warrant exercises Stock issued to nonemployees for service Equity based compensation - employees Option exercises Purchase of stock by officers and directors
2021-09-30
2021-08-13 4302.82 未披露 定期报告 2021-08-09
2021-08-13 4296.34 未披露
更多>>
From March 31, 2021 to June 30, 2021 Proceeds from the sale of common stock Warrant exercises 401(k) contributions paid in common stock Stock and options issued to nonemployees for service Option exercises
2021-06-30
2021-06-29 4273.91 未披露
更多>>
1.On June 23, 2021, the Underwriters exercised their over-allotment option to purchase 210,000 additional shares of common stock. The Offering of the 210,000 shares sold as a result of the exercise of the Underwriter’s over-allotment option closed on June 28, 2021.
2021-06-28
2021-06-11 4252.91 未披露
更多>>
1.Common stock the company is offering 1,400,000 shares. 2.The number of shares of common stock shown above to be outstanding after this offering is based on 41,129,065 shares outstanding as of June 1, 2021.
2021-06-11
2021-06-09 4112.91 未披露 定期报告 2021-06-01
2021-05-18 4090.66 未披露 定期报告 2021-05-07
2021-05-17 4082.40 未披露
更多>>
From December 31, 2020 To March 31, 2021 Warrant exercises 401(K) Contributions Paid In Common Stock Stock and options issued to nonemployees for service Option exercises
2021-03-31
2021-02-12 4052.93 未披露 定期报告 2021-02-05
2021-02-12 3976.71 未披露
更多>>
From OCTOBER 1, 2020 to December 31, 2020 Proceeds from the sale of common stock Warrant exercises Equity based compensation - employees 401(k) contributions paid in common stock Stock and options issued to nonemployees for service Option exercises
2020-12-31
2020-12-11 3975.64 未披露
更多>>
1.Common stock the company is offering 1,000,000 shares. 2.The number of shares of common stock shown above to be outstanding after this offering is based on 38,756,417 shares outstanding as of December 2, 2020.
2020-12-11
2020-12-09 3875.64 未披露 定期报告 2020-12-02
2020-12-29 3873.02 未披露
更多>>
From SEPTEMBER 30, 2019 to SEPTEMBER 30, 2020 Proceeds from the sale of common stock Warrant exercises 401(k) contributions paid in common stock Stock issued to nonemployees for service Stock option exercises Purchase of stock by officers and directors Shares issued for settlement of clinical research costs
2020-09-30
2020-08-10 3862.41 未披露 定期报告 2020-08-05
2020-08-10 3852.22 未披露
更多>>
from March 31,2020 to June 30,2020 Proceeds from the sale of common stock Warrant exercises 401(k) contributions paid in common stock Stock issued to nonemployees for service Shares issued for settlement of clinical research costs Option exercises
2020-06-30
2020-05-08 3763.39 未披露 定期报告 2020-05-05
2020-04-09 3743.68 未披露 定期报告 2020-04-06
2020-05-08 3733.64 未披露
更多>>
From December 31, 2019 to March 31, 2020 Proceeds from the sale of common stock Warrant exercises 401(k) contributions paid in common stock Stock issued to nonemployees for service Purchase of stock by officers and directors Option exercises
2020-03-31
2020-03-26 3730.99 未披露 定期报告 2020-03-26
2020-03-24 3667.94 未披露 定期报告 2020-03-20
2020-03-04 3653.67 未披露 定期报告 2020-02-21
2020-02-20 3642.74 未披露 定期报告 2020-02-14
2020-02-10 3639.01 未披露 定期报告 2020-02-05
2020-02-10 3599.51 未披露
更多>>
From September 30, 2019 to DECEMBER 31, 2019 Issuance of common stock Warrant exercises 401(k) contributions paid in common stock Stock issued to nonemployees for service Purchase of stock by officer
2019-12-31
2019-12-27 3599.06 未披露 定期报告 2019-12-27
2019-12-16 3538.00 未披露 定期报告 2019-12-11
2019-12-16 3523.18 未披露
更多>>
From September 30, 2018 to September 30, 2019 Warrant exercises 401(k) contributions paid in common stock Stock issued to nonemployees for service Equity based compensation - employees Option exercises Purchase of stock by officers and directors Shares issued for settlement of clinical research costs
2019-09-30
2019-08-20 3505.53 未披露 定期报告 2019-08-15
2019-08-14 3480.53 未披露 定期报告 2019-08-13
2019-08-14 3406.69 未披露
更多>>
From March 31, 2019 to June 30, 2019 Warrant exercises 401(k) contributions paid in common stock Stock issued to nonemployees for service Equity based compensation - employees Option exercises Purchase of stock by officers and directors
2019-06-30
2019-05-14 3370.29 未披露 定期报告 2019-05-09
2019-05-14 2995.16 未披露
更多>>
From DECEMBER 31, 2018 To MARCH 31, 2019 Warrant exercises 401(k) contributions paid in common stock Stock issued to nonemployees for service Equity based compensation - employees Shares issued for settlement of clinical research costs
2019-03-31
2019-03-26 2976.97 未披露 定期报告 2019-03-26
2019-02-14 2956.71 未披露 定期报告 2019-02-13
2019-02-11 2955.39 未披露 定期报告 2019-02-07
2019-01-18 2925.58 未披露 定期报告 2019-01-11
2019-02-14 2784.33 未披露 定期报告 2018-12-31
2018-12-19 2838.85 未披露 定期报告 2018-12-11
2018-10-23 2827.16 未披露 定期报告 2018-10-22
2018-12-19 2803.45 未披露
更多>>
From SEPTEMBER 30, 2017 To SEPTEMBER 30, 2018 Sale of common stock Warrant exercises 401(k) contributions paid in common stock Stock issued to nonemployees for service Employee stock purchases Conversion of notes payable and interest to common stock Shares issued for settlement of clinical research costs
2018-09-30
2018-08-31 2502.61 未披露 定期报告 2018-08-30
2018-08-20 2402.11 未披露 定期报告 2018-08-17
2018-08-14 2355.47 未披露 定期报告 2018-08-10
2018-08-14 2354.17 未披露 定期报告 2018-08-01
2018-08-03 2347.91 未披露 定期报告 2018-07-27
2018-07-27 2347.91 未披露 定期报告 2018-07-17
2018-08-14 1957.05 未披露 定期报告 2018-06-30
2018-06-22 1924.18 未披露 定期报告 2018-06-19
2018-05-24 1749.55 未披露 定期报告 2018-05-18
2018-05-15 1689.51 未披露 定期报告 2018-05-14
2018-05-15 1662.46 未披露 定期报告 2018-03-31
2018-02-12 1399.40 未披露 定期报告 2018-02-04
2018-01-05 1391.86 未披露 定期报告 2018-01-05
2018-02-12 1325.81 未披露 定期报告 2017-12-31
2017-12-29 1320.63 未披露
更多>>
On December 19, 2017 the Company received subscription agreements for the purchase of 1,289,478 shares of CEL-SCI common stock at a price of $1.90 in the principal amount of $2,450,000 from 19 investors. The common stock will be restricted unless registered. The purchasers of the common stock also received warrants which entitle the purchasers to acquire up to 1,289,478 shares of the Company’s common stock. The warrants are exercisable at a fixed price of $2.09 per share, will not be exercisable for 6 months and one day and will expire on December 18, 2022.
2017-12-21
2017-12-29 1190.31 未披露
更多>>
From SEPTEMBER 30, 2016 To SEPTEMBER 30, 2017 Sale of common stock 401(k) contributions paid in common stock Conversion of notes payable to common stock Stock issued to nonemployees for service Ergomed stock issuance Equity based compensation - employees
2017-09-30
2017-08-18 1008.24 未披露 定期报告 2017-08-18
2017-08-09 933.57 未披露 定期报告 2017-08-04
2017-08-09 921.87 未披露 定期报告 2017-06-30
2017-07-20 921.87 未披露
更多>>
CEL-SCI Corporation announced today that during its annual Shareholder's Meeting on June 12, 2017, a 1-for-25 reverse split was authorized for its outstanding shares of common stock. CEL-SCI expects the split to be implemented on June 15, 2017.
2017-06-15
2017-05-10 22982.73 未披露 定期报告 2017-05-08
2017-05-10 21647.83 未披露 定期报告 2017-03-31
2017-02-09 19096.55 未披露 定期报告 2017-02-03
2017-02-09 19093.13 未披露 定期报告 2016-12-31
2016-12-14 15596.21 未披露
更多>>
from September 30, 2015 to September 30, 2016 Sale of common stock 401(k) contributions paid in common stock Stock issued to nonemployees for service Equity based compensation - employees
2016-09-30
2016-08-09 14534.97 未披露 定期报告 2016-08-01
2016-08-09 14514.61 未披露 定期报告 2016-06-30
2016-06-09 13495.55 未披露 定期报告 2016-05-20
2016-05-10 13492.13 未披露 定期报告 2016-05-02
2016-05-10 13487.60 未披露 定期报告 2016-03-31
2016-02-09 13320.49 未披露 定期报告 2016-02-01
2016-02-09 13013.71 未披露 定期报告 2015-12-31
2016-12-14 18872.44 未披露 定期报告 2015-12-09
2015-12-11 12997.21 未披露 定期报告 2015-12-02
2015-12-11 11236.06 未披露
更多>>
from September 30, 2014 to September 30, 2015 Sale of stock 401(k) contributions paid in common stock Stock issued to nonemployees for service Forfeiture of unvested restricted stock Equity based compensation - employees
2015-09-30
2015-08-07 11208.12 未披露 定期报告 2015-08-04
2015-08-07 11202.71 未披露 定期报告 2015-06-30
2015-05-08 9160.83 未披露 定期报告 2015-05-01
2015-04-21 9157.41 未披露 定期报告 2015-04-14
2015-05-08 9154.91 未披露 定期报告 2015-03-31
2015-02-06 9154.24 未披露 定期报告 2015-02-02
2015-02-06 9148.33 未披露 定期报告 2014-12-31
2014-12-23 9134.55 未披露 定期报告 2014-12-11
2014-12-23 8190.25 未披露
更多>>
from September 30, 2013 to September 30, 2014 Sale of stock 401(k) contributions paid：in common stock Exercise of warrants Stock issued to nonemployees for service Stock issued for patents Issuance of restricted stock
2014-09-30
2014-08-08 7967.58 未披露 定期报告 2014-08-07
2014-08-08 6604.16 未披露 定期报告 2014-06-30
2014-05-30 6597.08 未披露 定期报告 2014-05-28
2014-05-12 6593.66 未披露 定期报告 2014-05-06
2014-05-12 5827.66 未披露 定期报告 2014-03-31
2014-02-10 5594.02 未披露 定期报告 2014-02-04
2014-02-10 5585.30 未披露 定期报告 2013-12-31
2013-12-27 4975.22 未披露 定期报告 2013-12-09
2013-12-27 3102.50 未披露
更多>>
from SEPTEMBER 30, 2012 to SEPTEMBER 30, 2013 Sale of stock 401(k) contributions paid in common stock Stock issued to nonemployees for service On June 25, 2013, CEL-SCI’s shareholders approved a reverse split of CEL-SCI’s common stock. The reverse split became effective on the NYSE MKT on September 25, 2013.
2013-09-30
2013-08-09 30990.53 未披露 定期报告 2013-07-30
2013-08-09 30985.53 未披露 定期报告 2013-06-30
2013-05-10 30923.43 未披露 定期报告 2013-03-31
2013-02-08 30896.04 未披露 定期报告 2013-01-31
2013-02-08 30891.04 未披露 定期报告 2012-12-31
2012-12-14 27321.33 未披露 定期报告 2012-12-04
2012-12-14 27311.33 未披露
更多>>
from SEPTEMBER 30, 2011 to SEPTEMBER 30, 2012 Sale of stock 401(k) contributions paid in common stock Exercise of w arrants and stock options Stock issued to nonemployees for service
2012-09-30
2012-08-09 27295.24 未披露 定期报告 2012-08-03
2012-08-09 27290.24 未披露 定期报告 2012-06-30
2012-05-10 25669.77 未披露 定期报告 2012-05-03
2012-05-10 25659.77 未披露 定期报告 2012-03-31
2012-02-09 24956.98 未披露 定期报告 2012-02-06
2012-02-09 23002.86 未披露 定期报告 2011-12-31
2011-12-23 22988.97 未披露 定期报告 2011-12-09
2011-12-23 21472.30 未披露
更多>>
from Sep 30,2010 to Sep 30,2011 Sale of stock 401(k) contributions paid in common stock Exercise of warrants and stock options Stock issued to nonemployees for service
2011-09-30
2011-08-09 21275.44 未披露 定期报告 2011-08-03
2011-08-09 21058.49 未披露 定期报告 2011-06-30
2011-05-16 20794.03 未披露 定期报告 2011-05-10
2011-05-16 20793.53 未披露 定期报告 2011-03-31
2011-02-09 20708.22 未披露 定期报告 2011-02-03
2011-02-09 20601.95 未披露 定期报告 2010-12-31
2010-12-13 20509.81 未披露 定期报告 2010-11-30
2010-12-13 20486.89 未披露
更多>>
from SEPTEMBER 30,2009 to SEPTEMBER 30,2010 401(k) contributions paid in common stock Exercise of warrants and stock options Stock issued to employees and nonemployees for service
2010-09-30
2010-08-16 20472.87 未披露 定期报告 2010-06-30
2010-05-17 20466.16 未披露 定期报告 2010-05-10
2010-05-17 20434.18 未披露 定期报告 2010-03-31
2009-01-13 12363.70 未披露 定期报告 2008-12-31
2009-01-13 12079.61 未披露
更多>>
from SEPTEMBER 30, 2007 to SEPTEMBER 30, 2008 Sale of common stock 401(k) contributions paid in common stock Issuance of common stock to employees Exercise of stock options Stock issued to non-employees for service
2008-09-30
2008-01-11 11572.91 未披露 定期报告 2007-11-30
2008-01-11 11567.87 未披露
更多>>
from SEPTEMBER 30, 2006 to SEPTEMBER 30, 2007 Private placement 401(k) contributions paid in common stock Issuance of common stock to employees Exercise of stock options Penalty shares issued Stock issued to nonemployees for service Payment of principal on convertible debt in common stock Conversion of convertible debt into common stock
2007-09-30
2007-01-17 8329.19 未披露 定期报告 2007-01-12
2007-01-17 8269.74 未披露
更多>>
from SEPTEMBER 30, 2005 to SEPTEMBER 30, 2006 Stock issued to non-employees for service Exercise of stock options 401(k) contributions paid in common stock Issuance of common stock to employees Issuance of common stock for equity line of credit Payment of interest on convertible debt in common stock Penalty shares issued Exercise of warrants Cashless exercise of warrants Private placement
2006-09-30
2006-04-25 8004.58 未披露 定期报告 2006-04-20
2006-04-25 7449.42 未披露
更多>>
from SEPTEMBER 30, 2004 to SEPTEMBER 30, 2005 Stock issued to nonemployees for service Exercise of stock options 401(k) contributions paid in common stock Issuance of common stock for equity line of credit Private placement
2005-09-30
2005-01-13 7226.92 未披露 定期报告 2004-12-31
2005-01-13 7214.74 未披露
更多>>
from SEPTEMBER 30, 2003 to SEPTEMBER 30, 2004 Exercise of warrants Stock issued to employees for service Stock issued to nonemployees for service Conversion of Series H convertible debt Interest on Series H convertible debt paid in common stock Exercise of options 401(k) contributions Issuance of common stock for equity line Sale of common stock
2004-09-30
2003-12-17 6512.14 未披露 定期报告 2003-12-01
2003-12-17 6116.63 未披露
更多>>
from SEPTEMBER 30, 2002 to SEPTEMBER 30, 2003 Conversion of Preferred Series E to common stock Exercise of warrants Stock issued to employees for service Stock issued to non-employees for service Dividends on Preferred Series E paid in common stock Conversion of Series F convertible debt Interest on Series F convertible debt paid in common stock Conversion of Series G convertible debt Interest on Series G convertible debt paid in common stock Conversion of Series H convertible debt Interest on Series H convertible debt paid in common stock Sale of common stock to Eastern Biotech Exercise of options 401(k) contributions Issuance of common stock for equity line
2003-09-30
2003-01-02 4479.96 未披露 定期报告 2002-11-30
2003-01-02 3725.51 0.12
更多>>
from SEPTEMBER 30, 2001 to SEPTEMBER 30, 2002 Exercise of warrants Stock issued to employees for service Stock issued to nonemployees for service Conversion of Preferred Series E to common stock Dividends on Preferred Series E paid in common stock Conversion of Series F convertible debt Interest on Series F convertible debt paid in common stock Conversion of Series G convertible debt Issuance-common stock 401(k) contributions Stock bonus to officer Issuance of common stock for equity line
2002-09-30
2001-12-31 2334.43 未披露 定期报告 2001-12-20
2001-12-31 2195.21 0.59
更多>>
from SEPTEMBER 30,2000 to SEPTEMBER 30,2001 Exchange of common stock for Preferred Series E Conversion of Preferred Series E to common stock Exercise of warrants Stock issued to employees for service Stock issued to non-employees for service Issuance - common stock 401(k) contributions Stock bonus to officer
2001-09-30
2000-12-27 2045.97 未披露
更多>>
from SEPTEMBER 30, 1999 to SEPTEMBER 30, 2000 Exercise of stock options Issuance - common stock 401(k) contributions Stock bonus to officer
2000-09-30
1999-12-29 1802.80 未披露 定期报告 1999-12-20
1999-12-29 1700.23 未披露
更多>>
from SEPTEMBER 30, 1998 to SEPTEMBER 30, 1999 Preferred Series D conversion Exercise of stock options 401(k) contributions Stock bonus to officer
1999-09-30
1999-01-15 1271.55 未披露 定期报告 1998-12-15
1999-01-15 1197.27 0.90
更多>>
from SEPTEMBER 30, 1997 to SEPTEMBER 30, 1998 Series D preferred stock, net of offering costs Series D conversion 401
1998-09-30
1997-12-24 1121.89 未披露 定期报告 1997-12-15
1997-12-24 1044.57 未披露
更多>>
from SEPTEMBER 30, 1996 to SEPTEMBER 30, 1997 Preferred Series A conversion Repurchase of Preferred B shares Preferred Series B conversion Issuance - Series C preferred stock Preferred Series C conversion Exercise of stock options Exercise of warrants Stock issued for acquisition of Multikine and Cell-Med's Heteroconjugate rights
1997-09-30
1996-12-30 838.26 未披露 定期报告 1996-12-17
1997-01-10 783.15 0.56
更多>>
from SEPTEMBER 30, 1995 to SEPTEMBER 30, 1996 Issuance - Series A preferred stock Preferred Series A Conversion Issuance - Series B preferred stock Common stock issued for cash Exercise of warrants Conversion of convertible debentures Stock issued for acquisition of VTI and Nippon-Zeon rights
1996-09-30
1996-07-17 533.82 未披露
更多>>
from SEPTEMBER 30, 1994 to SEPTEMBER 30, 1995 Common stock issued for cash On April 28, 1995 the stockholders of the Company approved a 10- for1 reverse split of the Company's outstanding common stock, which became effective on May 1, 1995.
1995-09-30
1996-07-17 418.82 未披露
更多>>
from SEPTEMBER 30, 1993 to SEPTEMBER 30, 1994 Net unrealized loss on marketable securities
1994-09-30
Common stock offered 3,875,000 shares by the company
From September 30, 2023 to December 31, 2023 401(k) contributions paid in common stock Stock issued to nonemployees for service Proceeds from the sale of common stock
Common stock offered 2,490,000 shares by the company
From September 30, 2022 to September 30, 2023 401(k) contributions paid in common stock Stock issued to nonemployees for service Proceeds from the sale of common stock 2014 Incentive Stock Forfeited
Common stock offered 2,500,000 shares by the company
From March 31, 2023 to June 30, 2023 2014 Incentive Stock Forfeited 401(k) contributions paid in common stock Proceeds from the sale of common stock Stock and options issued to nonemployees for service
Common stock offered 794,117 shares by the company
From December 31, 2022 to March 31, 2023 401(k) contributions paid in common stock Stock and options issued to nonemployees for service
From SEPTEMBER 30, 2022 to DECEMBER 31, 2022 Warrant exercises 401(k) contributions paid in common stock Stock and options issued to nonemployees for service 2014 Incentive Stock Forfeited
From September 30, 2021 to September 30, 2022 Warrant exercises 401(k) contributions paid in common stock Stock issued to nonemployees for service Option exercises
From MARCH 31, 2022 to JUNE 30, 2022 401(k) contributions paid in common stock Stock and options issued to nonemployees for service
From DECEMBER 31, 2021 to MARCH 31, 2022 Warrant exercises 401(k)contributions paid in common stock Stock and options issued to nonemployees for service
From OCTOBER 1, 2021 to DECEMBER 31, 2021 Warrant exercises 401(k) contributions paid in common stock Stock and options issued to nonemployees for service Option exercises
From September 30, 2020 to September 30, 2021 Proceeds from the sale of common stock Warrant exercises Stock issued to nonemployees for service Equity based compensation - employees Option exercises Purchase of stock by officers and directors
From March 31, 2021 to June 30, 2021 Proceeds from the sale of common stock Warrant exercises 401(k) contributions paid in common stock Stock and options issued to nonemployees for service Option exercises
1.On June 23, 2021, the Underwriters exercised their over-allotment option to purchase 210,000 additional shares of common stock. The Offering of the 210,000 shares sold as a result of the exercise of the Underwriter’s over-allotment option closed on June 28, 2021.
1.Common stock the company is offering 1,400,000 shares. 2.The number of shares of common stock shown above to be outstanding after this offering is based on 41,129,065 shares outstanding as of June 1, 2021.
From December 31, 2020 To March 31, 2021 Warrant exercises 401(K) Contributions Paid In Common Stock Stock and options issued to nonemployees for service Option exercises
From OCTOBER 1, 2020 to December 31, 2020 Proceeds from the sale of common stock Warrant exercises Equity based compensation - employees 401(k) contributions paid in common stock Stock and options issued to nonemployees for service Option exercises
1.Common stock the company is offering 1,000,000 shares. 2.The number of shares of common stock shown above to be outstanding after this offering is based on 38,756,417 shares outstanding as of December 2, 2020.
From SEPTEMBER 30, 2019 to SEPTEMBER 30, 2020 Proceeds from the sale of common stock Warrant exercises 401(k) contributions paid in common stock Stock issued to nonemployees for service Stock option exercises Purchase of stock by officers and directors Shares issued for settlement of clinical research costs
from March 31,2020 to June 30,2020 Proceeds from the sale of common stock Warrant exercises 401(k) contributions paid in common stock Stock issued to nonemployees for service Shares issued for settlement of clinical research costs Option exercises
From December 31, 2019 to March 31, 2020 Proceeds from the sale of common stock Warrant exercises 401(k) contributions paid in common stock Stock issued to nonemployees for service Purchase of stock by officers and directors Option exercises
From September 30, 2019 to DECEMBER 31, 2019 Issuance of common stock Warrant exercises 401(k) contributions paid in common stock Stock issued to nonemployees for service Purchase of stock by officer
From September 30, 2018 to September 30, 2019 Warrant exercises 401(k) contributions paid in common stock Stock issued to nonemployees for service Equity based compensation - employees Option exercises Purchase of stock by officers and directors Shares issued for settlement of clinical research costs
From March 31, 2019 to June 30, 2019 Warrant exercises 401(k) contributions paid in common stock Stock issued to nonemployees for service Equity based compensation - employees Option exercises Purchase of stock by officers and directors
From DECEMBER 31, 2018 To MARCH 31, 2019 Warrant exercises 401(k) contributions paid in common stock Stock issued to nonemployees for service Equity based compensation - employees Shares issued for settlement of clinical research costs
From SEPTEMBER 30, 2017 To SEPTEMBER 30, 2018 Sale of common stock Warrant exercises 401(k) contributions paid in common stock Stock issued to nonemployees for service Employee stock purchases Conversion of notes payable and interest to common stock Shares issued for settlement of clinical research costs
On December 19, 2017 the Company received subscription agreements for the purchase of 1,289,478 shares of CEL-SCI common stock at a price of $1.90 in the principal amount of $2,450,000 from 19 investors. The common stock will be restricted unless registered. The purchasers of the common stock also received warrants which entitle the purchasers to acquire up to 1,289,478 shares of the Company’s common stock. The warrants are exercisable at a fixed price of $2.09 per share, will not be exercisable for 6 months and one day and will expire on December 18, 2022.
From SEPTEMBER 30, 2016 To SEPTEMBER 30, 2017 Sale of common stock 401(k) contributions paid in common stock Conversion of notes payable to common stock Stock issued to nonemployees for service Ergomed stock issuance Equity based compensation - employees
CEL-SCI Corporation announced today that during its annual Shareholder's Meeting on June 12, 2017, a 1-for-25 reverse split was authorized for its outstanding shares of common stock. CEL-SCI expects the split to be implemented on June 15, 2017.
from September 30, 2015 to September 30, 2016 Sale of common stock 401(k) contributions paid in common stock Stock issued to nonemployees for service Equity based compensation - employees
from September 30, 2014 to September 30, 2015 Sale of stock 401(k) contributions paid in common stock Stock issued to nonemployees for service Forfeiture of unvested restricted stock Equity based compensation - employees
from September 30, 2013 to September 30, 2014 Sale of stock 401(k) contributions paid：in common stock Exercise of warrants Stock issued to nonemployees for service Stock issued for patents Issuance of restricted stock
from SEPTEMBER 30, 2012 to SEPTEMBER 30, 2013 Sale of stock 401(k) contributions paid in common stock Stock issued to nonemployees for service On June 25, 2013, CEL-SCI’s shareholders approved a reverse split of CEL-SCI’s common stock. The reverse split became effective on the NYSE MKT on September 25, 2013.
from SEPTEMBER 30, 2011 to SEPTEMBER 30, 2012 Sale of stock 401(k) contributions paid in common stock Exercise of w arrants and stock options Stock issued to nonemployees for service
from Sep 30,2010 to Sep 30,2011 Sale of stock 401(k) contributions paid in common stock Exercise of warrants and stock options Stock issued to nonemployees for service
from SEPTEMBER 30,2009 to SEPTEMBER 30,2010 401(k) contributions paid in common stock Exercise of warrants and stock options Stock issued to employees and nonemployees for service
from SEPTEMBER 30, 2007 to SEPTEMBER 30, 2008 Sale of common stock 401(k) contributions paid in common stock Issuance of common stock to employees Exercise of stock options Stock issued to non-employees for service
from SEPTEMBER 30, 2006 to SEPTEMBER 30, 2007 Private placement 401(k) contributions paid in common stock Issuance of common stock to employees Exercise of stock options Penalty shares issued Stock issued to nonemployees for service Payment of principal on convertible debt in common stock Conversion of convertible debt into common stock
from SEPTEMBER 30, 2005 to SEPTEMBER 30, 2006 Stock issued to non-employees for service Exercise of stock options 401(k) contributions paid in common stock Issuance of common stock to employees Issuance of common stock for equity line of credit Payment of interest on convertible debt in common stock Penalty shares issued Exercise of warrants Cashless exercise of warrants Private placement
from SEPTEMBER 30, 2004 to SEPTEMBER 30, 2005 Stock issued to nonemployees for service Exercise of stock options 401(k) contributions paid in common stock Issuance of common stock for equity line of credit Private placement
from SEPTEMBER 30, 2003 to SEPTEMBER 30, 2004 Exercise of warrants Stock issued to employees for service Stock issued to nonemployees for service Conversion of Series H convertible debt Interest on Series H convertible debt paid in common stock Exercise of options 401(k) contributions Issuance of common stock for equity line Sale of common stock
from SEPTEMBER 30, 2002 to SEPTEMBER 30, 2003 Conversion of Preferred Series E to common stock Exercise of warrants Stock issued to employees for service Stock issued to non-employees for service Dividends on Preferred Series E paid in common stock Conversion of Series F convertible debt Interest on Series F convertible debt paid in common stock Conversion of Series G convertible debt Interest on Series G convertible debt paid in common stock Conversion of Series H convertible debt Interest on Series H convertible debt paid in common stock Sale of common stock to Eastern Biotech Exercise of options 401(k) contributions Issuance of common stock for equity line
from SEPTEMBER 30, 2001 to SEPTEMBER 30, 2002 Exercise of warrants Stock issued to employees for service Stock issued to nonemployees for service Conversion of Preferred Series E to common stock Dividends on Preferred Series E paid in common stock Conversion of Series F convertible debt Interest on Series F convertible debt paid in common stock Conversion of Series G convertible debt Issuance-common stock 401(k) contributions Stock bonus to officer Issuance of common stock for equity line
from SEPTEMBER 30,2000 to SEPTEMBER 30,2001 Exchange of common stock for Preferred Series E Conversion of Preferred Series E to common stock Exercise of warrants Stock issued to employees for service Stock issued to non-employees for service Issuance - common stock 401(k) contributions Stock bonus to officer
from SEPTEMBER 30, 1999 to SEPTEMBER 30, 2000 Exercise of stock options Issuance - common stock 401(k) contributions Stock bonus to officer
from SEPTEMBER 30, 1998 to SEPTEMBER 30, 1999 Preferred Series D conversion Exercise of stock options 401(k) contributions Stock bonus to officer
from SEPTEMBER 30, 1997 to SEPTEMBER 30, 1998 Series D preferred stock, net of offering costs Series D conversion 401
from SEPTEMBER 30, 1996 to SEPTEMBER 30, 1997 Preferred Series A conversion Repurchase of Preferred B shares Preferred Series B conversion Issuance - Series C preferred stock Preferred Series C conversion Exercise of stock options Exercise of warrants Stock issued for acquisition of Multikine and Cell-Med's Heteroconjugate rights
from SEPTEMBER 30, 1995 to SEPTEMBER 30, 1996 Issuance - Series A preferred stock Preferred Series A Conversion Issuance - Series B preferred stock Common stock issued for cash Exercise of warrants Conversion of convertible debentures Stock issued for acquisition of VTI and Nippon-Zeon rights
from SEPTEMBER 30, 1994 to SEPTEMBER 30, 1995 Common stock issued for cash On April 28, 1995 the stockholders of the Company approved a 10- for1 reverse split of the Company's outstanding common stock, which became effective on May 1, 1995.
from SEPTEMBER 30, 1993 to SEPTEMBER 30, 1994 Net unrealized loss on marketable securities